Skip to main content
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.48
-0.12 (-0.77%)
At close: Nov 13, 2026, 4:00 PM EST
15.20
-0.28 (-1.81%)
After-hours: Nov 13, 2026, 7:45 PM EST

Nurix Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Market Capitalization
1,6911,7921,5663025841,286
Market Cap Growth
37.09%14.43%419.13%-48.35%-54.57%-22.36%
Enterprise Value
7081,4201,13641184942
Last Close Price
15.4817.6822.116.2212.3928.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
2.4121.3428.713.9215.1243.22
PB Ratio
1.753.332.971.511.923.76
P/TBV Ratio
1.753.332.971.511.923.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
EV/Sales Ratio
1.0116.9120.820.534.7631.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Debt / Equity Ratio
0.070.100.050.150.040.04
Debt / FCF Ratio
0.18-----
Net Debt / Equity Ratio
-1.01-1.00-1.10-1.32-1.19-1.23
Net Debt / EBITDA Ratio
-3.301.942.841.782.013.62
Net Debt / FCF Ratio
-2.662.043.202.952.104.66
Asset Turnover
0.820.120.110.200.090.07
Quick Ratio
8.196.876.383.324.394.57
Current Ratio
8.447.026.463.404.514.70
Return on Equity (ROE)
43.99%-49.63%-53.22%-57.10%-55.84%-37.05%
Return on Assets (ROA)
21.08%-26.30%-25.98%-25.10%-25.72%-16.88%
Return on Capital Employed (ROCE)
27.20%-47.50%-37.10%-57.70%-53.10%-28.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Earnings Yield
17.37%-14.76%-12.36%-47.71%-30.88%-9.12%
FCF Yield
21.87%-14.70%-11.61%-29.75%-29.45%-7.00%
Buyback Yield / Dilution
-32.80%-29.12%-23.52%-11.79%-13.32%-173.68%
SEC Filings: 10-K · 10-Q